Officials with the U.S. Food and Drug Administration recently approved the VisuMax Femtosecond Laser, which is designed for small incision lenticule extraction (SMILE) procedures to decrease or end nearsightedness.
Leaders with the U.S. Food and Drug Administration (FDA) recently approved of an additional indication for the Sapien 3 and Sapien XT transcatheter heart valves, designed for patients who have aortic valve stenosis.
The scientists behind the pivotal DECIDE study recently published a new post-hoc analysis to demonstrate a notably higher number of people who receive Zinbryta treatments and show no evidence of disease activity (NEDA) over patients with Avonex intramuscular injections.
Leaders with the Parkinson’s Disease Foundation (PDF), part of the Parkinson’s Foundation, recently announced the eighth part of its PD ExpertBriefings series about unmet needs in Parkinson’s education.
Johnson & Johnson recently partnered with Global Citizen, a social action platform, to improve the trajectory of human health on a global scale, granting each individual the chance to have a healthy future.
The U.S. Preventive Services Task Force (USPSTF) recently conducted new studies to evaluate scientific evidence and found that routine screening for genital herpes using blood tests is not supported with evidence.
The U.S. Food and Drug Administration (FDA) recently approved of marketing for two new computerized cognitive tests to determine a person’s cognitive functioning after receiving a suspected concussion or brain injury.
The U.S. Food and Drug Administration (FDA) recently stated that there was sufficient evidence of a novel investigational oral beta-secretase cleaving enzyme (BACE) inhibitor E2609 to begin phase III clinical studies.
The National Institutes of Health (NIH) recently funded a worldwide study that suggests surgically removing the thymus gland from patients with myasthenia gravis can bring about positive outcomes for the patients.
The National Institute of Allergy and Infectious Diseases (NIAID), a branch of the National Institutes of Health (NIH), recently found that approximately 80 percent of preschool children with peanut allergies had positive responses to oral immunotherapy.
The Partnership to Fight Chronic Disease (PFCD) recently launched the Federal Communications Commission’s (FCC’s) Connect2Health Task Force (C2H), which is dedicated to the new Mapping Broadband Health in America technology.